TGF‐β1 has been shown to be activated by MSCs‐EVs in lung cancer cells, while silencing TGF‐β1 expression in MSCs can enhance the anti‐proliferative and pro‐apoptotic effects of MSCs on lung cancer cells via MSCs‐EVs.11 Here, TGFB1 is linked to lung carcinoma.